Back to basics: two useful articles to pass along

The Prostate Cancer Foundation posted two useful and basic articles on its blog site this December that may be useful resources for men concerned about their risk for or newly diagnosed with prostate cancer or monitoring their PSA over time (for any one of all sorts of possible reasons). … READ MORE …

Feedback to USPSTF on new, draft recommendations on PSA screening

As many readers will be aware, the U.S. Preventive Services Task Force (USPSTF) recently issued new, draft guidance on the role of testing for risk of prostate cancer, and most particularly on the use of PSA testing in men of 55 years and older. All public comment on the proposed new draft recommendations is due on or before May 8 upcoming. … READ MORE …

ASCO issues new PCO in treatment of chemotherapy-naive CRPC

ASCO has just released a new set of provisional guidance (a “provisional clinical opinion” or PCO) on the second-line treatment of men with chemotherapy-naive, castration-resistant prostate cancer (CRPC), i.e., men who are progressing on initial androgen deprivation therapy (ADT or “hormone” therapy) but who haven’t had docetaxel-based chemotherapy yet. … READ MORE …

New draft USPSTF guidance on screening for risk of prostate cancer (the details)

As indicated earlier this morning, the US Preventive Services Task Force (USPSTF) has issued new draft guidance on screening for risk of prostate cancer. Access to all the relevant details is provided below: … READ MORE …

How do mpMRI and MRI/TRUS fusion biopsies actually work?

As our regular readers will be well aware, the combination of multiparametric MRI (mpMRI) data with transrectal ultrasound (TRUS)-guided biopsy techniques are rapidly becoming more common in both the diagnosis of prostate cancer and in monitoring risk for prostate cancer in men on active surveillance protocols. … READ MORE …

New recommendations from the AUA through “Choosing Wisely” initiative

Yesterday the American Urology Association (AUA) issued a second set of five recommendations to its members through the Choosing Wisely initiative (which is coordinated by the ABIM Foundation). Two of these recommendations were specific to risk for prostate cancer and its management. … READ MORE …

New “six-point” statement about prostate cancer screening (redux)

Three weeks ago we mentioned a new six-point statement about PSA screening developed at a meeting in Melbourne, Australia. We would note that an updated set of information about this statement is now available on the BJU International web site. … READ MORE …